Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients

BACKGROUND: Systemic lupus erythematosus (SLE) patients have a striking increase in cardiovascular (CV) comorbidity not fully explained by the Framingham risk score. Recent evidence from in vitro studies suggests that type I interferons (IFN) could promote premature CV disease (CVD) in SLE. We asses...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Somers, Emily C., Zhao, Wenpu, Lewis, Emily E., Wang, Lu, Wing, Jeffrey J., Sundaram, Baskaran, Kazerooni, Ella A., McCune, W. Joseph, Kaplan, Mariana J.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2012
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351452/
https://ncbi.nlm.nih.gov/pubmed/22606325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037000
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki